Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Complex and Mixed

Explore clinical trials studying Neoplasms, Complex and Mixed. Study availability and eligibility vary by location and protocol.

399 public trials 75 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Complex and Mixed trial results

Active, Not Recruiting

Cabozantinib S-malate and Nivolumab in Treating Patients With Advanced, Recurrent, or Metastatic Endometrial Cancer

NCT03367741

Conditions
Advanced Endometrial Carcinoma, Carcinosarcoma, Endometrial Neoplasms, +19 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
View all 34 locations
View Trial Details
Active, Not Recruiting

Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma

NCT00602667

Conditions
Brain Diseases, Brain Neoplasms, Brain and Central Nervous System Tumors, +11 more
Locations
  • Lucile Packard Children's Hospital at Stanford University Medical Center Palo Alto, California, United States
  • Rady Children's Hospital San Diego, California, United States
  • Children's Hospitals and Clinics of Minnesota - St. Paul Saint Paul, Minnesota, United States
  • St. Jude Children's Research Hospital Memphis, Tennessee, United States
View Trial Details
Active, Not Recruiting

Paediatric Hepatic International Tumour Trial

NCT03017326

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations
  • St. Anna Kinderspital Vienna, Austria
  • Cliniques Universitaires Saint-Luc Brussels, Woluwe-Saint-Lambert, Belgium
  • University Hospital Motol Prague, Czechia
  • Kuopio University Hospital Kuopio, Finland
View all 32 locations
View Trial Details
Active, Not Recruiting

Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers

NCT05691504

Conditions
Adnexal Diseases, Advanced Endometrial Carcinoma, Carcinosarcoma, +28 more
Locations
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
  • National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
View Trial Details
Active, Not Recruiting

PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer

NCT01737619

Conditions
Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Adenocarcinoma, Endometrial Serous Adenocarcinoma, +8 more
Locations
  • Lyndon Baines Johnson General Hospital Houston, Texas, United States
  • M D Anderson Cancer Center Houston, Texas, United States
  • The Woman's Hospital of Texas Houston, Texas, United States
  • MD Anderson Regional Care Center-Katy Houston, Texas, United States
View Trial Details
Active, Not Recruiting

Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors

NCT05407441

Conditions
Atypical Teratoid Rhabdoid Tumor, Chordoma, Epithelioid Sarcoma, +11 more
Locations
  • Boston Children's Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Texas Children's Hospital Houston, Texas, United States
View Trial Details

Related conditions